Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud Aljurf

Showing results (251-260 of 403) with videos related to

Pageof 41
Sort By:
Blood|May 1, 2012
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working PartyJudith C Marsh, Andrea Bacigalupo, Hubert Schrezenmeier, et al.
Hematology/Oncology and Stem Cell Therapy|January 18, 2019
Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) GroupJaleel Mohammed, Mahmoud Aljurf, Abdulaziz Althumayri, et al.
Transplantation and Cellular Therapy|November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell TransplantationSurbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
Haematologica|May 18, 2023
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow TransplantationSimona Pagliuca, Austin G Kulasekararaj, Dirk-Jan Eikema, et al.
Haematologica|July 3, 2025
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia ReportPedro Henrique Prata, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Blood|March 17, 2024
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell diseaseAdetola A Kassim, Josu de la Fuente, Erfan Nur, et al.
American Journal of Hematology|October 20, 2022
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMTYves Chalandon, Giulia Sbianchi, Luuk Gras, et al.
Bone Marrow Transplantation|February 7, 2020
Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT)Ghuzayel AlDawsari, Alaa Elhaddad, Riad El Fakih, et al.
The Lancet. Haematology|July 28, 2022
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issuesNina Worel, Mahmoud Aljurf, Chloe Anthias, et al.
Haematologica|March 23, 2023
Graft-<i>versus</i>-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMTRaynier Devillier, Dirk-Jan Eikema, Carlo Dufour, et al.
Pageof 41

Showing results (251-260 of 403) with videos related to

Sort By:
Pageof 41
Blood|May 1, 2012
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working PartyJudith C Marsh, Andrea Bacigalupo, Hubert Schrezenmeier, et al.
Hematology/Oncology and Stem Cell Therapy|January 18, 2019
Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) GroupJaleel Mohammed, Mahmoud Aljurf, Abdulaziz Althumayri, et al.
Transplantation and Cellular Therapy|November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell TransplantationSurbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
Haematologica|May 18, 2023
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow TransplantationSimona Pagliuca, Austin G Kulasekararaj, Dirk-Jan Eikema, et al.
Haematologica|July 3, 2025
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia ReportPedro Henrique Prata, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Blood|March 17, 2024
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell diseaseAdetola A Kassim, Josu de la Fuente, Erfan Nur, et al.
American Journal of Hematology|October 20, 2022
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMTYves Chalandon, Giulia Sbianchi, Luuk Gras, et al.
Bone Marrow Transplantation|February 7, 2020
Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT)Ghuzayel AlDawsari, Alaa Elhaddad, Riad El Fakih, et al.
The Lancet. Haematology|July 28, 2022
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issuesNina Worel, Mahmoud Aljurf, Chloe Anthias, et al.
Haematologica|March 23, 2023
Graft-<i>versus</i>-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMTRaynier Devillier, Dirk-Jan Eikema, Carlo Dufour, et al.
Pageof 41